AU2001249477A1 - Lactams as inhibitors of a-beta protein production - Google Patents
Lactams as inhibitors of a-beta protein productionInfo
- Publication number
- AU2001249477A1 AU2001249477A1 AU2001249477A AU4947701A AU2001249477A1 AU 2001249477 A1 AU2001249477 A1 AU 2001249477A1 AU 2001249477 A AU2001249477 A AU 2001249477A AU 4947701 A AU4947701 A AU 4947701A AU 2001249477 A1 AU2001249477 A1 AU 2001249477A1
- Authority
- AU
- Australia
- Prior art keywords
- lactams
- inhibitors
- protein production
- beta protein
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003951 lactams Chemical class 0.000 title 1
- 230000014616 translation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19251700P | 2000-03-28 | 2000-03-28 | |
| US60192517 | 2000-03-28 | ||
| PCT/US2001/009703 WO2001072324A1 (en) | 2000-03-28 | 2001-03-27 | Lactams as inhibitors of a-beta protein production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001249477A1 true AU2001249477A1 (en) | 2001-10-08 |
Family
ID=22709993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001249477A Abandoned AU2001249477A1 (en) | 2000-03-28 | 2001-03-27 | Lactams as inhibitors of a-beta protein production |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1267906A1 (en) |
| JP (1) | JP2003528150A (en) |
| AU (1) | AU2001249477A1 (en) |
| CA (1) | CA2401120A1 (en) |
| WO (1) | WO2001072324A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878363B2 (en) | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
| TW200502221A (en) | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| EP1636196A1 (en) * | 2003-03-14 | 2006-03-22 | AstraZeneca AB | Novel lactams and uses thereof |
| ZA200603165B (en) * | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| JP2008523141A (en) * | 2004-12-14 | 2008-07-03 | アストラゼネカ・アクチエボラーグ | New molecular probe |
| US7536962B2 (en) | 2005-04-19 | 2009-05-26 | Kamterter Ii, L.L.C. | Systems for the control and use of fluids and particles |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970705A2 (en) * | 1996-12-23 | 1998-10-31 | Warren J. Porter | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING "beta" -AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| JP2002518483A (en) * | 1998-06-22 | 2002-06-25 | エラン ファーマシューティカルズ,インコーポレイテッド | Compounds for inhibiting β-amyloid peptide release and / or their synthesis |
| HRP990246A2 (en) * | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
-
2001
- 2001-03-27 AU AU2001249477A patent/AU2001249477A1/en not_active Abandoned
- 2001-03-27 EP EP01922708A patent/EP1267906A1/en not_active Withdrawn
- 2001-03-27 CA CA002401120A patent/CA2401120A1/en not_active Abandoned
- 2001-03-27 JP JP2001570285A patent/JP2003528150A/en active Pending
- 2001-03-27 WO PCT/US2001/009703 patent/WO2001072324A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2401120A1 (en) | 2001-10-04 |
| EP1267906A1 (en) | 2003-01-02 |
| JP2003528150A (en) | 2003-09-24 |
| WO2001072324A1 (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001257006A1 (en) | Substituted lactams as inhibitors of abeta protein production | |
| IL151576A0 (en) | Cyclic lactams as inhibitors of a-beta protein production | |
| AU2001239791A1 (en) | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production | |
| IL142816A0 (en) | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
| AU7997600A (en) | Amino lactam sulfonamides as inhibitors of abeta protein production | |
| AU2003265235A1 (en) | Non-affinity purification of proteins | |
| AU2002235189A1 (en) | Production of 6-aminocaproic acid | |
| AU2001228309A1 (en) | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv | |
| IL147629A0 (en) | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | |
| AU2002362197A1 (en) | Method of stabilizing protein | |
| AU2002339348A1 (en) | Inhibition of STAT-1 | |
| AU2001260674A1 (en) | TNF-alpha production inhibitors | |
| AU2002367147A1 (en) | Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS | |
| AU2002232819A1 (en) | Methods for the production of multimeric proteins, and related compositions | |
| AU2001244692A1 (en) | Novel crystal form of pyrrolidylthiocarbapenem derivative | |
| AU2002214286A1 (en) | Method of profiling protein | |
| HUP0202519A3 (en) | Production of proteins | |
| AU2001230207A1 (en) | Method for the production of 1-amino-3-aryl-uracils | |
| AU2001288092A1 (en) | Method of crystallization | |
| AU2001249477A1 (en) | Lactams as inhibitors of a-beta protein production | |
| AU2002303265A1 (en) | Small molecule inhibitors of secretion of proteins encoded by are-mrnas | |
| AU2001280436A1 (en) | Process to increase protein stability | |
| AU2001265935A1 (en) | Production of biohydrolysates | |
| AU2003246098A1 (en) | Oxamidination process of carbonyl compounds | |
| AU2002234066A1 (en) | Process for the production of amides |